A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- Author
- GILBERT, Mark R1 ; DIGNAM, James J3 5 ; JERAJ, Robert10 ; BROWN, Paul D1 ; JAECKLE, Kurt A11 ; SCHIFF, David12 ; STIEBER, Volker W13 ; BRACHMAN, David G14 ; WERNER-WASIK, Maria4 ; TREMONT-LUKATS, Ivo W1 ; SULMAN, Erik P1 ; ALDAPE, Kenneth D1 ; ARMSTRONG, Terri S1 2 ; CURRAN, Walter J15 ; MEHTA, Minesh P16 ; WEFEL, Jeffrey S1 ; BLUMENTHAL, Deborah T6 ; VOGELBAUM, Michael A7 ; COLMAN, Howard8 ; CHAKRAVARTI, Arnab9 ; PUGH, Stephanie3 ; MINHEE WON3
[1] University of Texas M.D. Anderson Cancer Center, Houston, United States
[2] University of Texas Health Science Center School of Nursing, Houston, United States
[3] American College of Radiology, Philadelphia, United States
[4] Thomas Jefferson University, Philadelphia, United States
[5] University of Chicago, Chicago, United States
[6] Tel-Aviv Medical Center, Tel Aviv, Israel
[7] Cleveland Clinic, Cleveland, United States
[8] University of Utah, Salt Lake City, United States
[9] Ohio State University, Columbus, United States
[10] University of Wisconsin, Madison, United States
[11] Mayo Clinic, Jacksonville, FL, United States
[12] University of Virginia, Charlottesville, United States
[13] Southeast Cancer Control Consortium, Winston-Salem, NC, United States
[14] Barrow Neurologic Institute, Phoenix, AZ, United States
[15] Emory University, Atlanta, United States
[16] University of Maryland, Baltimore, United States - Source
The New England journal of medicine. 2014, Vol 370, Num 8, pp 699-708, 10 p ; ref : 30 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiangiogénique Anticancéreux Bévacizumab Diagnostic Facteur croissance endothélium vasculaire Glioblastome Immunomodulateur Médecine Anti-VEGF Anticorps monoclonal Cancer Gliome malin Pathologie du système nerveux central Pathologie du système nerveux Tumeur maligne
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Bevacizumab Diagnosis Vascular endothelium growth factor Glioblastoma Immunomodulator Medicine Monoclonal antibody Cancer Malignant glioma Central nervous system disease Nervous system diseases Malignant tumor
- Keyword (es)
- Antiangiogenico Anticanceroso Bevacizumab Diagnóstico Factor crecimiento endotelio vascular Glioblastoma Inmunomodulador Medicina Anticuerpo monoclonal Cáncer Glioma maligno Sistema nervosio central patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17E Tumors of the nervous system. Phacomatoses
- Discipline
- Generalities in medical sciences Neurology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28149271
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1308573 
https://dx.doi.org/10.1056/NEJMoa1308573
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308573\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"699\";s:8:\"\u0000*\u0000epage\";s:3:\"708\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GILBERT\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:15:\"DIGNAM, James J\";i:1;s:13:\"JERAJ, Robert\";i:2;s:13:\"BROWN, Paul D\";i:3;s:15:\"JAECKLE, Kurt A\";i:4;s:13:\"SCHIFF, David\";i:5;s:17:\"STIEBER, Volker W\";i:6;s:17:\"BRACHMAN, David G\";i:7;s:19:\"WERNER-WASIK, Maria\";i:8;s:21:\"TREMONT-LUKATS, Ivo W\";i:9;s:14:\"SULMAN, Erik P\";i:10;s:17:\"ALDAPE, Kenneth D\";i:11;s:18:\"ARMSTRONG, Terri S\";i:12;s:16:\"CURRAN, Walter J\";i:13;s:15:\"MEHTA, Minesh P\";i:14;s:16:\"WEFEL, Jeffrey S\";i:15;s:21:\"BLUMENTHAL, Deborah T\";i:16;s:20:\"VOGELBAUM, Michael A\";i:17;s:14:\"COLMAN, Howard\";i:18;s:18:\"CHAKRAVARTI, Arnab\";i:19;s:15:\"PUGH, Stephanie\";i:20;s:10:\"MINHEE WON\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308573\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"699\";s:8:\"\u0000*\u0000epage\";s:3:\"708\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GILBERT\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:15:\"DIGNAM, James J\";i:1;s:13:\"JERAJ, Robert\";i:2;s:13:\"BROWN, Paul D\";i:3;s:15:\"JAECKLE, Kurt A\";i:4;s:13:\"SCHIFF, David\";i:5;s:17:\"STIEBER, Volker W\";i:6;s:17:\"BRACHMAN, David G\";i:7;s:19:\"WERNER-WASIK, Maria\";i:8;s:21:\"TREMONT-LUKATS, Ivo W\";i:9;s:14:\"SULMAN, Erik P\";i:10;s:17:\"ALDAPE, Kenneth D\";i:11;s:18:\"ARMSTRONG, Terri S\";i:12;s:16:\"CURRAN, Walter J\";i:13;s:15:\"MEHTA, Minesh P\";i:14;s:16:\"WEFEL, Jeffrey S\";i:15;s:21:\"BLUMENTHAL, Deborah T\";i:16;s:20:\"VOGELBAUM, Michael A\";i:17;s:14:\"COLMAN, Howard\";i:18;s:18:\"CHAKRAVARTI, Arnab\";i:19;s:15:\"PUGH, Stephanie\";i:20;s:10:\"MINHEE WON\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308573\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308573\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"699\";s:8:\"\u0000*\u0000epage\";s:3:\"708\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GILBERT\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:15:\"DIGNAM, James J\";i:1;s:13:\"JERAJ, Robert\";i:2;s:13:\"BROWN, Paul D\";i:3;s:15:\"JAECKLE, Kurt A\";i:4;s:13:\"SCHIFF, David\";i:5;s:17:\"STIEBER, Volker W\";i:6;s:17:\"BRACHMAN, David G\";i:7;s:19:\"WERNER-WASIK, Maria\";i:8;s:21:\"TREMONT-LUKATS, Ivo W\";i:9;s:14:\"SULMAN, Erik P\";i:10;s:17:\"ALDAPE, Kenneth D\";i:11;s:18:\"ARMSTRONG, Terri S\";i:12;s:16:\"CURRAN, Walter J\";i:13;s:15:\"MEHTA, Minesh P\";i:14;s:16:\"WEFEL, Jeffrey S\";i:15;s:21:\"BLUMENTHAL, Deborah T\";i:16;s:20:\"VOGELBAUM, Michael A\";i:17;s:14:\"COLMAN, Howard\";i:18;s:18:\"CHAKRAVARTI, Arnab\";i:19;s:15:\"PUGH, Stephanie\";i:20;s:10:\"MINHEE WON\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308573\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"699\";s:8:\"\u0000*\u0000epage\";s:3:\"708\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GILBERT\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:15:\"DIGNAM, James J\";i:1;s:13:\"JERAJ, Robert\";i:2;s:13:\"BROWN, Paul D\";i:3;s:15:\"JAECKLE, Kurt A\";i:4;s:13:\"SCHIFF, David\";i:5;s:17:\"STIEBER, Volker W\";i:6;s:17:\"BRACHMAN, David G\";i:7;s:19:\"WERNER-WASIK, Maria\";i:8;s:21:\"TREMONT-LUKATS, Ivo W\";i:9;s:14:\"SULMAN, Erik P\";i:10;s:17:\"ALDAPE, Kenneth D\";i:11;s:18:\"ARMSTRONG, Terri S\";i:12;s:16:\"CURRAN, Walter J\";i:13;s:15:\"MEHTA, Minesh P\";i:14;s:16:\"WEFEL, Jeffrey S\";i:15;s:21:\"BLUMENTHAL, Deborah T\";i:16;s:20:\"VOGELBAUM, Michael A\";i:17;s:14:\"COLMAN, Howard\";i:18;s:18:\"CHAKRAVARTI, Arnab\";i:19;s:15:\"PUGH, Stephanie\";i:20;s:10:\"MINHEE WON\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308573\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"699\";s:8:\"\u0000*\u0000epage\";s:3:\"708\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GILBERT\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:15:\"DIGNAM, James J\";i:1;s:13:\"JERAJ, Robert\";i:2;s:13:\"BROWN, Paul D\";i:3;s:15:\"JAECKLE, Kurt A\";i:4;s:13:\"SCHIFF, David\";i:5;s:17:\"STIEBER, Volker W\";i:6;s:17:\"BRACHMAN, David G\";i:7;s:19:\"WERNER-WASIK, Maria\";i:8;s:21:\"TREMONT-LUKATS, Ivo W\";i:9;s:14:\"SULMAN, Erik P\";i:10;s:17:\"ALDAPE, Kenneth D\";i:11;s:18:\"ARMSTRONG, Terri S\";i:12;s:16:\"CURRAN, Walter J\";i:13;s:15:\"MEHTA, Minesh P\";i:14;s:16:\"WEFEL, Jeffrey S\";i:15;s:21:\"BLUMENTHAL, Deborah T\";i:16;s:20:\"VOGELBAUM, Michael A\";i:17;s:14:\"COLMAN, Howard\";i:18;s:18:\"CHAKRAVARTI, Arnab\";i:19;s:15:\"PUGH, Stephanie\";i:20;s:10:\"MINHEE WON\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
